Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Current practice pattern for dry eye patients in South Korea: a multicenter study.

Song JS, Hyon JY, Lee D, Chung E, Choi C, Lee J, Kim HM; Korea Corneal Disease Study Group.

Korean J Ophthalmol. 2014 Apr;28(2):115-21. doi: 10.3341/kjo.2014.28.2.115. Epub 2014 Mar 14.

2.

Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.

Jee D, Park SH, Kim MS, Kim EC.

Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):5081-9. doi: 10.1167/iovs.14-14483.

PMID:
24994869
3.

Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy.

Hyon JY, Kim HM, Lee D, Chung ES, Song JS, Choi CY, Lee J; Korean Corneal Disease Study Group.

Korean J Ophthalmol. 2014 Jun;28(3):197-206. doi: 10.3341/kjo.2014.28.3.197. Epub 2014 May 19.

4.

Efficacy and Safety of Carbomer-Based Lipid-Containing Artificial Tear Formulations in Patients With Dry Eye Syndrome.

Chung SH, Lim SA, Tchach H.

Cornea. 2016 Feb;35(2):181-6. doi: 10.1097/ICO.0000000000000660.

PMID:
26509769
5.

The pathophysiology, diagnosis, and treatment of dry eye disease.

Messmer EM.

Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82. doi: 10.3238/arztebl.2015.0071. Review.

6.

Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.

Wilson SE, Perry HD.

Ophthalmology. 2007 Jan;114(1):76-9. Epub 2006 Oct 27.

PMID:
17070588
7.

Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study.

Byun YS, Rho CR, Cho K, Choi JA, Na KS, Joo CK.

Korean J Ophthalmol. 2011 Dec;25(6):369-74. doi: 10.3341/kjo.2011.25.6.369. Epub 2011 Nov 22.

8.

Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.

Toker E, Asfuroğlu E.

Cornea. 2010 Feb;29(2):133-40. doi: 10.1097/ICO.0b013e3181acf68d.

PMID:
19966564
9.

Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.

Sullivan BD, Crews LA, Sönmez B, de la Paz MF, Comert E, Charoenrook V, de Araujo AL, Pepose JS, Berg MS, Kosheleff VP, Lemp MA.

Cornea. 2012 Sep;31(9):1000-8. doi: 10.1097/ICO.0b013e318242fd60.

PMID:
22475641
10.

Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.

Rao SN.

J Ocul Pharmacol Ther. 2011 Dec;27(6):603-9. doi: 10.1089/jop.2011.0073. Epub 2011 Oct 14.

PMID:
21999340
11.

Survey of eye practitioners' preference of diagnostic tests and treatment modalities for dry eye in Ghana.

Asiedu K, Kyei S, Ayobi B, Agyemang FO, Ablordeppey RK.

Cont Lens Anterior Eye. 2016 Dec;39(6):411-415. doi: 10.1016/j.clae.2016.08.001. Epub 2016 Aug 6.

PMID:
27507732
12.

A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.

Kim EC, Choi JS, Joo CK.

Am J Ophthalmol. 2009 Feb;147(2):206-213.e3. doi: 10.1016/j.ajo.2008.08.015. Epub 2008 Oct 9.

PMID:
18848318
13.
14.

Dry eye in LASIK patients.

Azuma M, Yabuta C, Fraunfelder FW, Shearer TR.

BMC Res Notes. 2014 Jul 3;7:420. doi: 10.1186/1756-0500-7-420.

15.

[Effect of anti-inflammatory therapy on the treatment of dry eye syndrome].

Mrukwa-Kominek E, Rogowska-Godela A, Gierek-Ciaciura S.

Klin Oczna. 2007;109(1-3):79-84. Review. Polish.

PMID:
17687921
16.

The course of dry eye after phacoemulsification surgery.

Cetinkaya S, Mestan E, Acir NO, Cetinkaya YF, Dadaci Z, Yener HI.

BMC Ophthalmol. 2015 Jun 30;15:68. doi: 10.1186/s12886-015-0058-3.

17.

Cost of dry eye treatment in an Asian clinic setting.

Waduthantri S, Yong SS, Tan CH, Shen L, Lee MX, Nagarajan S, Hla MH, Tong L.

PLoS One. 2012;7(6):e37711. doi: 10.1371/journal.pone.0037711. Epub 2012 Jun 11.

18.

Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease.

Moore QL, De Paiva CS, Pflugfelder SC.

Am J Ophthalmol. 2015 Jul;160(1):135-42.e1. doi: 10.1016/j.ajo.2015.04.008. Epub 2015 Apr 11.

19.

Evaluation of topical cyclosporine for the treatment of dry eye disease.

Perry HD, Solomon R, Donnenfeld ED, Perry AR, Wittpenn JR, Greenman HE, Savage HE.

Arch Ophthalmol. 2008 Aug;126(8):1046-50. doi: 10.1001/archopht.126.8.1046.

PMID:
18695097
20.

Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.

Demiryay E, Yaylali V, Cetin EN, Yildirim C.

Eye Contact Lens. 2011 Sep;37(5):312-5. doi: 10.1097/ICL.0b013e31822563be.

PMID:
21792057

Supplemental Content

Support Center